Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires. [electronic resource]
- Cancer research Mar 2001
- 2047-54 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't